Transcatheter Aortic Valve Replacement : Procedure and Outcomes - 19/11/19
, Philippe Pibarot, DVM, PhD, Josep Rodés-Cabau, MDRésumé |
Initially, transcatheter aortic valve replacement (TAVR) was only used in patients with severe symptomatic aortic stenosis and prohibitive risk for surgical aortic valve replacement. Subsequently, TAVR was extended to patients with high and intermediate surgical risk. Recently, the results of randomized trials in low-surgical-risk patients showed superiority or noninferiority of TAVR versus surgical aortic valve replacement in this population. Procedural outcomes have been improved. Long-term durability of transcatheter heart valves remains to be confirmed. This article presents the evolution and current status of TAVR, with respect to the different types of devices and procedures as well as its outcomes.
Le texte complet de cet article est disponible en PDF.Keywords : Aortic stenosis, Interventional cardiology, Outcomes, Paravalvular regurgitation, Structural valve deterioration, Transcatheter aortic valve replacement, Transcatheter heart valve
Plan
| Disclosure: Dr E. Salaun has nothing to disclose. Dr P. Pibarot received research grants from Edwards Lifesciences and Medtronic for echo corelab analyses in transcatheter aortic valve replacement. Dr J. Rodés-Cabau has received institutional research grants from Edwards Lifesciences. |
Vol 38 - N° 1
P. 115-128 - février 2020 Retour au numéro
Article précédent
- Planning for Success : Pre-procedural Evaluation for Transcatheter Aortic Valve Replacement
- Vivian G. Ng, Rebecca T. Hahn, Tamim M. Nazif
- Sex Differences in the Pathophysiology, Diagnosis, and Management of Aortic Stenosis
- Nancy Côté, Marie-Annick Clavel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?